Biotech Values

[10nisman]

Sandoz/MNTA/Teva Lawsuit

A couple of questions regarding the lawsuit for Dew and board.

What does NVS/Sandoz get out of the lawsuit? Why would NVS/Sandoz care to pay legal costs for a lawsuit that gives them little upside (i.e., NVS share price isn't discounted with a TEVA overhang like MNTA's share price) besides to stick to Teva management?

Why do the lawsuit now versus last month or some time next year?

Could it mean NVS/Sandoz is interested in acquiring MNTA or its interest in mLovenox however both parties cannot come to an agreement without getting TEVA out of the picture and they hope the lawsuit will help them do that?

Or could NVS/Sandoz and MNTA management teams know something about Teva's situation that we all do not (some internal Teva issues, issues between Teva and its partner/manufacturer, etc.) and they strongly believe this lawsuit at this time will lead to greatly enhancing the value of their companies?

IMHO, NVS/Sandoz and MNTA management teams are good managers of their resources (time and money) and it would seem odd to me for them to waste resources on this lawsuit unless they strongly believed it could yield them a good return.

10nis